L-Nutra named Innovator Partner for the Longevity Show 2026

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Precision nutrition pioneer L-Nutra will bring fasting-mimicking science and clinically validated longevity programs to the Longevity Show.

The Longevity Show 2026 has announced L-Nutra as an Innovator Partner, signaling the rising influence of evidence-based nutrition in extending healthspan and tackling the chronic diseases of aging.

Nutrition has always been medicine’s awkward middle child – everywhere at once, yet oddly ignored. We’ve seen it relegated to flimsy patient pamphlets or over-analyzed in academic journals, but it’s rarely been treated with the kind of systematic, pharmaceutical-grade discipline that actually moves the needle.

Nutrition as infrastructure

Andrea Ghirardi, L-Nutra’s CEO EMEA, isn’t heading to the Business Stage to talk about lifestyle tweaks or wellness trends. Instead, he’s framing precision nutrition as a piece of essential infrastructure – a strategic necessity for societies that are rapidly graying. This shift from ‘nice-to-have’ to ‘must-hire’ continues in a closed-door roundtable, where industry leaders will hammer out how to actually bake metabolic resilience into formal healthcare. For those who want to see the mechanics in action, L-Nutra’s floor presence moves past the white papers to show how fasting-mimicking and medical nutrition programs work in practice.

Behind the brand sits a formidable evidence base. In partnership with 18 global university research centers, L-Nutra has developed formulations inspired by precision nutrition and powered by cellular longevity science; programs supported by 47 clinical trials and protected by 137 granted patents. Numbers matter here – because in a sector crowded with biohacks and bravado, validation is currency.

Metabolic levers, pulled on purpose

The engine driving L-Nutra is its fasting-mimicking technology – essentially a way to hack the body’s biology. It’s designed to pull the same metabolic levers as a water-only fast, triggering things like autophagy and IGF-1 modulation, but without the safety risks or the sheer misery of actually starving. It’s less about ‘dieting’ and more about precisely re-tuning nutrient-sensing networks to spark cellular repair. The flagship Prolon longevity program, alongside medical nutrition therapies targeting chronic conditions, reflects a reframing that feels quietly radical: food not as fuel alone, nor as wellness theatre, but as programmable intervention.

“L-Nutra is a science-backed innovator transforming lives through its pioneering fasting-mimicking products,” said Phil Newman, cofounder of the Longevity Show and CEO of Longevity.Technology. “The company works closely with clinics and medical partners worldwide to deliver the proven metabolic health benefits of fasting in a clinically supported way. My family and I have personally experienced the benefits of the Fasting Mimicking Diet, and I’m proud that L-Nutra is supporting our show in bringing this important science and technology to the longevity community and broader public.”

As health systems strain under the compounding burdens of metabolic dysfunction, oncologic risk and neurodegenerative decline, the notion that nutrition might serve as frontline infrastructure – preventative, therapeutic and economically strategic – is gaining traction. L-Nutra’s presence at the Longevity Show is not merely sponsorship; it is signal. A marker of where the field is heading. Food as code. Fasting as platform. Longevity, engineered.

To learn more about partnership and exhibitor opportunities at The Longevity Show 2026, contact the Sponsor & Exhibitor team.

The Longevity Show opens its doors on 26–27 June 2026 at Tobacco Dock, London. Early bird tickets for all tiers are now available at www.longevityshow.com until 28 February 2026.

Photograph courtesy of L-Nutra
LTUI: 2536

L-Nutra

Longevity level(s):

  • Level 3: Longevity biohacking
    Companies that manufacture ingredients and dietary supplements, or produce equipment such as red light therapy, cryonic chambers, and enhanced exercise equipment to maintain the metabolism and replace cellular function lost with the progression of age.
  • Level 4: Longevity clinical services
    Professionally qualified clinics that offer diagnosis of health and aging biomarkers; clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age.
  • Level 6: Aging disease prevention therapeutics
    Therapeutic interventions that control aging drivers to prevent aging diseases from occurring, like the current wave of GLP-1 agonists that prevent type 2 diabetes through metabolic interventions that also are proving effective in mitigating cardiovascular and neurological diseases.

Overview

L-Nutra is a nutrition technology company pioneering the discovery, design, and commercialization of plant-based nutrition programs and therapeutics targeting cellular aging and chronic metabolic disease. The company develops fasting-mimicking diet formulations and interventional nutrition therapies designed to activate cellular rejuvenation mechanisms including autophagy and cellular reprogramming. L-Nutra operates across consumer wellness and clinical care divisions, with its flagship product Prolon and medical division L-Nutra Health focused on metabolic health restoration and disease remission. Supported by 47 clinical trials and 137 granted patents, the company aims to redefine nutrition as a primary therapeutic modality for extending healthspan and preventing age-related disease.

Access all data points on DLT:

  • Financial Data
  • Patents
  • Technology
  • Management
  • Advisory Board
  • News
  • Classifications
  • Similar Companies
Expand

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

This field is hidden when viewing the form

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form